Keywords: ablynx, deal, novartis, extended, bi, milestone, ghent

Ablynx deal with Novartis extended; BI milestone

Article | 16 February 2009

Ghent, Belgium-based Ablynx, a pioneer in the discovery and development of Nanobodies, a novel class of antibody-derived therapeutic proteins, says ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Boehringer Ingelheim

Drug Discovery

Go to company listing